--- title: "A Look At Tenet Healthcare (THC) Valuation After Strong Q4 Beat And Upgraded 2026 Outlook" type: "News" locale: "en" url: "https://longbridge.com/en/news/279191614.md" description: "Tenet Healthcare (THC) reported strong Q4 2025 earnings, exceeding estimates and updating its 2026 outlook. The stock price is $227.63, with a 1-day return of 1.29% and a 1-year total return of 85.56%. Analysts suggest a fair value of $240.60, indicating it may be undervalued. The company is shifting towards a diversified care network, focusing on outpatient services. However, risks include potential reimbursement pressures and labor shortages. Investors are encouraged to explore other opportunities in the healthcare sector." datetime: "2026-03-16T02:25:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/279191614.md) - [en](https://longbridge.com/en/news/279191614.md) - [zh-HK](https://longbridge.com/zh-HK/news/279191614.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/279191614.md) | [繁體中文](https://longbridge.com/zh-HK/news/279191614.md) # A Look At Tenet Healthcare (THC) Valuation After Strong Q4 Beat And Upgraded 2026 Outlook Tenet Healthcare (THC) is back in focus after reporting fourth quarter 2025 earnings that exceeded consensus estimates, updating its 2026 outlook, and continuing an active share repurchase program. See our latest analysis for Tenet Healthcare. At a share price of $227.63, Tenet Healthcare has seen a 1-day share price return of 1.29%, a 90-day share price return of 15.36% and a 1-year total shareholder return of 85.56%. This reflects strong momentum that aligns with the recent earnings beat, 2026 guidance and ongoing buybacks, despite short term pullbacks and insider selling activity. If Tenet’s recent move has you rethinking your healthcare exposure, it could be a good time to scan for other opportunities in the sector, starting with 33 healthcare AI stocks. With earnings ahead of expectations, 2026 guidance pointing to higher revenue and adjusted EBITDA, and an active buyback in place, the real question is whether Tenet still trades at a discount or if the market is already pricing in more growth. ## Most Popular Narrative: 5.4% Undervalued Tenet Healthcare's narrative fair value of $240.60 sits above the last close at $227.63, which is why many investors are paying attention to how this story is framed. > _Tenet has spent years repositioning itself away from a hospital-heavy model toward a more diversified care network. Its ambulatory surgery centers, outpatient facilities, and specialized service lines now play a much larger role in revenue and profitability. That shift matters. Outpatient settings tend to be more efficient, less capital-intensive, and better aligned with how care is delivered today. Patients want faster access, lower costs, and continuity across services, especially for conditions that require ongoing support rather than one-time interventions._ Read the complete narrative. Want to see what sits behind that valuation gap? According to yiannisz, the fair value leans heavily on outpatient growth, behavioral care integration, and resilient margins. The focus is on how those operating shifts feed into cash flows, discount rates, and future earnings power. The full narrative lays out the numbers that connect these ideas to the $240.60 figure. **Result: Fair Value of $240.60 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, this story can change if reimbursement pressure hits margins in hospital operations or if labor shortages persist, keeping staffing costs elevated. Find out about the key risks to this Tenet Healthcare narrative. ## Next Steps With both risks and rewards in play, the story here is clearly not one sided. It makes sense to move quickly and dig into the underlying data yourself to decide where you stand, starting with 2 key rewards and 4 important warning signs. ## Looking for more investment ideas? If Tenet has sharpened your focus on quality opportunities, do not stop here. Use the Simply Wall St screener to uncover other stocks that could fit your plan. - Target value opportunities by scanning our list of 48 high quality undervalued stocks that pair strong fundamentals with prices that may not fully reflect them. - Prioritise resilience by reviewing 68 resilient stocks with low risk scores that score well on stability so short term swings are less likely to knock your portfolio off course. - Get ahead of the crowd by checking a screener containing 26 high quality undiscovered gems before they land on everyone else’s radar. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Valuation is complex, but we're here to simplify it. Discover if Tenet Healthcare might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md) - [Tenet Healthcare Corporation (THC.US)](https://longbridge.com/en/quote/THC.US.md) - [iShares US Healthcare Providers ETF (IHF.US)](https://longbridge.com/en/quote/IHF.US.md) - [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md) - [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md) - [Stt Strt® SPDR® S&P®HlthCrSvcsETF (XHS.US)](https://longbridge.com/en/quote/XHS.US.md) ## Related News & Research - [Bernstein Reaffirms Their Hold Rating on Agilon Health (AGL)](https://longbridge.com/en/news/281231279.md) - [Healthcare Provider Triples Talent Pipeline and Boosts Applicants Per Opening 17% with ICIMS Candidate Experience Management](https://longbridge.com/en/news/281195659.md) - [Idorsia Ltd (IDIA) Receives a Rating Update from a Top Analyst](https://longbridge.com/en/news/281283879.md) - [Thank you, seniors. Healthcare spending is pumping up economic and job growth.](https://longbridge.com/en/news/281661389.md) - [Breaking down the booming March jobs report](https://longbridge.com/en/news/281661049.md)